Total Payments
$131,843
2024 Payments
$28,385
Companies
21
Transactions
257
Medicare Patients
2,164
Medicare Billing
$171,251
Payment Breakdown by Category
Other$106,975 (81.1%)
Consulting$14,138 (10.7%)
Travel$6,078 (4.6%)
Food & Beverage$4,399 (3.3%)
Education$253.19 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,975 | 41 | 81.1% |
| Consulting Fee | $14,138 | 3 | 10.7% |
| Travel and Lodging | $6,078 | 33 | 4.6% |
| Food and Beverage | $4,399 | 172 | 3.3% |
| Education | $253.19 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $129,889 | 152 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $453.97 | 27 | $0 (2024) |
| Insmed, Inc. | $241.35 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $205.53 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $191.68 | 12 | $0 (2024) |
| Philips Electronics North America Corporation | $161.53 | 5 | $0 (2023) |
| GENZYME CORPORATION | $87.34 | 6 | $0 (2023) |
| Electromed, Inc. | $86.93 | 4 | $0 (2023) |
| Grifols USA, LLC | $86.73 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $78.99 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,385 | 44 | GlaxoSmithKline, LLC. ($28,046) |
| 2023 | $56,940 | 56 | GlaxoSmithKline, LLC. ($56,719) |
| 2022 | $18,857 | 38 | GlaxoSmithKline, LLC. ($18,499) |
| 2021 | $10,362 | 47 | GlaxoSmithKline, LLC. ($9,969) |
| 2020 | $7,334 | 29 | GlaxoSmithKline, LLC. ($7,075) |
| 2019 | $9,732 | 29 | GlaxoSmithKline, LLC. ($9,581) |
| 2018 | $220.51 | 13 | AstraZeneca Pharmaceuticals LP ($123.74) |
| 2017 | $13.58 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13.58) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $42.88 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $52.08 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $103.18 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $44.12 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $48.91 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $47.57 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $205.85 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Pulmonology | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $78.99 | General |
| Category: Immunology | ||||||
| 07/12/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $72.71 | General |
| 07/12/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $41.64 | General |
| 07/12/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $40.25 | General |
| 07/12/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $18.41 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 476 | 602 | $82,773 | $28,640 |
| 2022 | 12 | 543 | 677 | $100,931 | $39,145 |
| 2021 | 17 | 770 | 1,264 | $163,210 | $67,258 |
| 2020 | 12 | 375 | 582 | $89,883 | $36,208 |
Total Patients
2,164
Total Services
3,125
Medicare Billing
$171,251
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 136 | 253 | $39,215 | $17,554 | 44.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 42 | 42 | $10,867 | $5,337 | 49.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 22 | 22 | $6,750 | $1,990 | 29.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 17 | 17 | $5,027 | $1,537 | 30.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 73 | 76 | $10,146 | $665.76 | 6.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 83 | 86 | $4,750 | $648.23 | 13.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 75 | 78 | $4,473 | $507.00 | 11.3% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 15 | 15 | $1,235 | $254.10 | 20.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Facility | 2023 | 13 | 13 | $312.78 | $147.03 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 174 | $32,745 | $13,208 | 40.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $19,534 | $8,432 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 67 | 82 | $12,710 | $6,294 | 49.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 34 | 34 | $8,797 | $4,903 | 55.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 22 | 22 | $6,481 | $2,007 | 31.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 18 | 19 | $5,513 | $1,716 | 31.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 25 | 25 | $1,750 | $612.37 | 35.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 43 | 44 | $5,108 | $401.26 | 7.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 48 | 51 | $2,591 | $400.92 | 15.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 36 | $1,980 | $342.32 | 17.3% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 17 | 18 | $1,481 | $317.52 | 21.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 30 | 31 | $1,463 | $204.71 | 14.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 14 | 14 | $479.18 | $203.95 | 42.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 16 | 19 | $247.00 | $85.62 | 34.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 47 | $53.58 | $16.72 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 351 | $73,710 | $33,124 | 44.9% |
About Dr. Francis Lee, MD
Dr. Francis Lee, MD is a Pulmonary Disease healthcare provider based in Ogdensburg, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932169083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Lee, MD has received a total of $131,843 in payments from pharmaceutical and medical device companies, with $28,385 received in 2024. These payments were reported across 257 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($106,975).
As a Medicare-enrolled provider, Lee has provided services to 2,164 Medicare beneficiaries, totaling 3,125 services with total Medicare billing of $171,251. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Ogdensburg, NY
- Active Since 03/24/2006
- Last Updated 09/09/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1932169083
Products in Payments
- AREXVY (Drug) $55,981
- TRELEGY ELLIPTA (Drug) $34,894
- ANORO (Drug) $3,648
- FASENRA (Drug) $244.56
- GLASSIA (Biological) $241.58
- Arikayce (Drug) $241.35
- DUPIXENT (Biological) $166.33
- (8874) inCourage (Device) $161.53
- OFEV (Drug) $135.88
- FASENRA (Biological) $134.05
- NUCALA (Biological) $103.37
- SMARTVEST (Device) $86.93
- Prolastin-C Liquid (Biological) $86.73
- FISHER & PAYKEL HEALTHCARE (Device) $75.43
- TEZSPIRE (Biological) $58.84
- ANORO ELLIPTA (Drug) $44.10
- SPIRIVA RESPIMAT (Drug) $44.09
- SYMBICORT (Drug) $42.19
- CHARTIS CATHETER (Device) $38.18
- XARELTO (Drug) $26.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.